Are your clients asking about Ozempic? Are you hearing colleagues debate the risks vs. benefits of incretin-based therapy (GLP-1, GIP)? Are you feeling stuck somewhere in the middle?

In this Dietitian Learning Lab, Sarah Hormachea, MS, RD, CDCES, BC-ADM will help you sort fact from fiction when it comes to incretin-based therapies. We’ll walk through six of the biggest questions dietitians are fielding right now - like do they worsen disordered eating or clash with HAES? And we'll unpack what the research says.